Arpasiri Soodsakorn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Arpasiri Soodsakorn has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Darunee Owittayakul
Department of Advanced General Dentistry and Dental Public Health, Faculty of Dentistry, Chiang Mai University, Chiang Mai, Thailand
1 shared publication - Jitjiroj Ittichaicharoen
Department of Oral Biology and Oral Diagnostic Sciences, Faculty of Dentistry, Chiang Mai University, Chiang Mai 50200, Thailand
1 shared publication - Marut Wongtapin
Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
1 shared publication - Phenphichar Wanachantararak
Dentistry Research Center, Faculty of Dentistry, Chiang Mai University, Chiang Mai, Thailand
1 shared publication - Siriwoot Sookkhee
Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
1 shared publication - Wantida Chaiyana
Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand
1 shared publication
Latest Publications
- Open Access
- 17 November 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (22) , 2941
A Randomized Trial in Older Adults of a Flavor-Enhanced Coconut Oil-Based Mouthwash: Clinical Safety, Antimicrobial Efficacy, and User Satisfaction
Background/Objectives: Fungal and bacterial infections are major contributors to oral diseases in older adults. Although chlorhexidine (CHX) is widely recognized for its antimicrobial efficacy, its prolonged use is constrained by adverse effects. Virgin coconut oil (VCO) possesses antimicrobial properties; however, its high viscosity reduces acceptability. This study aimed to develop a flavor-enhanced coconut oil-based mouthwash (FCoMW) and evaluate its clinical safety, antimicrobial efficacy, and user satisfaction. Methods: A 14-day randomized controlled trial was conducted in older adults at the Faculty of Dentistry, Chiang Mai University, Thailand (April–July, 2024). Participants were randomly allocated by simple randomization to FCoMW, CHX, and normal saline solution (NSS). The evaluator was blinded. Assessments included burning sensation, oral mucosal alterations, changes in oral Candida and bacterial counts, and user satisfaction. Results: Among 51 participants (NSS: 17; CHX: 16; FCoMW: 18), FCoMW significantly reduced oral Candida counts by Day 14 (p < 0.0001), with efficacy comparable to CHX. CHX achieved greater bacterial reduction (p < 0.05). No adverse effects occurred with FCoMW. User satisfaction was high for scent, freshness, and overall acceptability. Conclusions: FCoMW is safe, well-accepted, and efficacious against oral Candida, offering a natural alternative to chlorhexidine for long-term use in older adults.
- 17 November 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (22) , 2941
Open AccessA Randomized Trial in Older Adults of a Flavor-Enhanced Coconut Oil-Based Mouthwash: Clinical Safety, Antimicrobial Efficacy, and User Satisfaction
Background/Objectives: Fungal and bacterial infections are major contributors to oral diseases in older adults. Although chlorhexidine (CHX) is widely recognized for its antimicrobial efficacy, its prolonged use is constrained by adverse effects. Virgin coconut oil (VCO) possesses antimicrobial properties; however, its high viscosity reduces acceptability. This study aimed to develop a flavor-enhanced coconut oil-based mouthwash (FCoMW) and evaluate its clinical safety, antimicrobial efficacy, and user satisfaction. Methods: A 14-day randomized controlled trial was conducted in older adults at the Faculty of Dentistry, Chiang Mai University, Thailand (April–July, 2024). Participants were randomly allocated by simple randomization to FCoMW, CHX, and normal saline solution (NSS). The evaluator was blinded. Assessments included burning sensation, oral mucosal alterations, changes in oral Candida and bacterial counts, and user satisfaction. Results: Among 51 participants (NSS: 17; CHX: 16; FCoMW: 18), FCoMW significantly reduced oral Candida counts by Day 14 (p < 0.0001), with efficacy comparable to CHX. CHX achieved greater bacterial reduction (p < 0.05). No adverse effects occurred with FCoMW. User satisfaction was high for scent, freshness, and overall acceptability. Conclusions: FCoMW is safe, well-accepted, and efficacious against oral Candida, offering a natural alternative to chlorhexidine for long-term use in older adults.